Stern DM - Search Results

1

The biology of the receptor for advanced glycation end products and its ligands.

Schmidt AM, Yan SD, Yan SF, Stern DM. Schmidt AM, et al. Among authors: stern dm. Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. doi: 10.1016/s0167-4889(00)00087-2. Biochim Biophys Acta. 2000. PMID: 11108954 Free article. Review.

2

Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.

Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, Stern DM, Schmidt AM. Wendt T, et al. Among authors: stern dm. Curr Atheroscler Rep. 2002 May;4(3):228-37. doi: 10.1007/s11883-002-0024-4. Curr Atheroscler Rep. 2002. PMID: 11931721 Review.

3

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.

Stern DM, Yan SD, Yan SF, Schmidt AM. Stern DM, et al. Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9. Ageing Res Rev. 2002. PMID: 12039445 Review.

4

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.

Hudson BI, Bucciarelli LG, Wendt T, Sakaguchi T, Lalla E, Qu W, Lu Y, Lee L, Stern DM, Naka Y, Ramasamy R, Yan SD, Yan SF, D'Agati V, Schmidt AM. Hudson BI, et al. Among authors: stern dm. Arch Biochem Biophys. 2003 Nov 1;419(1):80-8. doi: 10.1016/j.abb.2003.08.030. Arch Biochem Biophys. 2003. PMID: 14568011 Review.

5

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.

Stern D, Yan SD, Yan SF, Schmidt AM. Stern D, et al. Adv Drug Deliv Rev. 2002 Dec 7;54(12):1615-25. doi: 10.1016/s0169-409x(02)00160-6. Adv Drug Deliv Rev. 2002. PMID: 12453678 Review.

6

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products.

Chen Y, Yan SS, Colgan J, Zhang HP, Luban J, Schmidt AM, Stern D, Herold KC. Chen Y, et al. J Immunol. 2004 Jul 15;173(2):1399-405. doi: 10.4049/jimmunol.173.2.1399. J Immunol. 2004. PMID: 15240736

7

RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling.

Chaney MO, Stine WB, Kokjohn TA, Kuo YM, Esh C, Rahman A, Luehrs DC, Schmidt AM, Stern D, Yan SD, Roher AE. Chaney MO, et al. Biochim Biophys Acta. 2005 Jun 30;1741(1-2):199-205. doi: 10.1016/j.bbadis.2005.03.014. Epub 2005 Apr 19. Biochim Biophys Acta. 2005. PMID: 15882940 Free article.

8

RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.

Schmidt AM, Stern DM. Schmidt AM, et al. Among authors: stern dm. Trends Endocrinol Metab. 2000 Nov;11(9):368-75. doi: 10.1016/s1043-2760(00)00311-8. Trends Endocrinol Metab. 2000. PMID: 11042467 Free article. Review.

9

RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.

Schmidt AM, Hofmann M, Taguchi A, Yan SD, Stern DM. Schmidt AM, et al. Among authors: stern dm. Semin Thromb Hemost. 2000;26(5):485-93. doi: 10.1055/s-2000-13204. Semin Thromb Hemost. 2000. PMID: 11129404 Review.

10

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann MA, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern DM, Schmidt AM. Kislinger T, et al. Among authors: stern dm. Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):905-10. doi: 10.1161/01.atv.21.6.905. Arterioscler Thromb Vasc Biol. 2001. PMID: 11397695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters